CSPC Pharmaceutical-UnspoadrCSPCY
13F holders, Q4 2025 (December 31)2holders
0new positions
0sold out
$4.32avg. 13F price*
At the end of Q4 2025, 2 institutions reported holding CSPC Pharmaceutical-Unspoadr (CSPCY) in their 13F filings, unchanged from Q3 2025. 0 opened new positions and 0 sold out. The largest holders were Rhumbline Advisers ($17K) and PNC Financial Services Group, Inc. ($928).
- Company
- CSPC Pharmaceutical-Unspoadr
- Filed as
- 1SPC PHARM ADR (Q4 2025)
- CUSIP
- 12591J207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 1,869 shares bought, net +1,869 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Rhumbline Advisers | 0.00% | Add +95.1% | 3,834 | $17K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 223 | $928 |
"% of holder's portfolio" is CSPCY's weight in each manager's 13F, not the share of CSPC Pharmaceutical-Unspoadr the manager owns.